Nuzenio

Agio Maintained

Agio Maintained news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Timeline

Fri, 07 Aug 2026 16:47:42 GMTAGIO Maintained by JP Morgan -- Price Target Raised to $34 - GuruFocus
Wed, 05 Aug 2026 05:38:00 GMTAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Agios Pharma (AGIO), Novavax (NVAX) and Keros Therapeutics (KROS) - theglobeandmail.com
Sun, 02 Aug 2026 14:40:05 GMTAgios: Buy Rating Reiterated on Strong AQVESME Uptake and Pipeline Progress, Price Target Maintained at $46 - TipRanks
Fri, 31 Jul 2026 23:12:14 GMTAGIO Maintained by Citigroup -- Price Target Raised to $52.00 - GuruFocus
Fri, 31 Jul 2026 13:36:00 GMTTruist Financial Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Announces Target Price $39 - Moomoo
Thu, 30 Jul 2026 14:04:28 GMTAgios Pharmaceuticals Q2 Earnings Call Highlights - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Agio Maintained.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.